Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma, The Journal of Experimental Medicine, vol.81, issue.6, pp.851-862, 2003. ,
DOI : 10.1084/jem.20022089
The molecular pathogenesis of primary mediastinal large B-cell lymphoma, Blood, vol.118, issue.10, pp.2659-2669, 2011. ,
DOI : 10.1182/blood-2011-05-326538
Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma, N Engl J Med, vol.368, pp.1408-1416, 2013. ,
Primary mediastinal large B-cell lymphoma, Cancer Treatment Reviews, vol.41, issue.6, pp.476-485, 2015. ,
DOI : 10.1016/j.ctrv.2015.04.006
Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma, Nature Genetics, vol.362, issue.4, pp.329-335, 2014. ,
DOI : 10.1038/ng.2900
Distinct types of diffuse large B-cell lymphoma identified by gene expression
profiling, Nature, vol.303, issue.6769, pp.503-511, 2000. ,
DOI : 10.1038/35000501
Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA Study, Clinical cancer research : an official journal of the American Association for Cancer Research, pp.2919-2928, 2016. ,
DOI : 10.1158/1078-0432.CCR-15-2305
URL : https://hal.archives-ouvertes.fr/hal-01442496
The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma, Blood, vol.102, issue.12, pp.3871-3879, 2003. ,
DOI : 10.1182/blood-2003-06-1841
Forkhead Box Protein P1 Expression in Mucosa-Associated Lymphoid Tissue Lymphomas Predicts Poor Prognosis and Transformation to Diffuse Large B-Cell Lymphoma, Journal of Clinical Oncology, vol.24, issue.16, pp.2490-2497, 2006. ,
DOI : 10.1200/JCO.2006.05.6150
Foxp1 is an essential transcriptional regulator of B cell development, Nature Immunology, vol.11, issue.8, pp.819-826, 2006. ,
DOI : 10.1016/S0092-8674(00)00188-4
Downregulation of FOXP1 is required during germinal center B-cell function, Blood, vol.121, issue.21, pp.4311-4320, 2013. ,
DOI : 10.1182/blood-2012-10-462846
Deregulated FOX genes in Hodgkin lymphoma, Genes, Chromosomes and Cancer, vol.118, issue.11, pp.917-933, 2014. ,
DOI : 10.1002/gcc.22204
Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways, Proceedings of the National Academy of Sciences, vol.105, issue.36, pp.13520-13525, 2008. ,
DOI : 10.1073/pnas.0804295105
t(3;14)(p14;q32) Results in aberrant expression ofFOXP1 in a case of diffuse large B-cell lymphoma, Genes, Chromosomes and Cancer, vol.19, issue.2, pp.164-168, 2006. ,
DOI : 10.1002/gcc.20278
T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma, Leukemia, vol.14, pp.652-658, 2005. ,
DOI : 10.1073/PNAS.050007597
The forkhead transcription factor FOXP1 represses human plasma cell differentiation, Blood, vol.126, issue.18, pp.2098-2109, 2015. ,
DOI : 10.1182/blood-2015-02-626176
Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1, Blood, vol.117, issue.23, pp.6227-6236, 2011. ,
DOI : 10.1182/blood-2010-10-312231
MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy, Nature Reviews Cancer, vol.39, issue.12, pp.849-864, 2011. ,
DOI : 10.1038/nrc3166
MicroRNAs in B-cell lymphomas: how a complex biology gets more complex, Leukemia, vol.9, issue.5, pp.1004-1017, 2015. ,
DOI : 10.1182/blood-2008-11-189407
The role of miRNAs in the pathogenesis and diagnosis of B-cell lymphomas, Blood, vol.120, issue.9, 2012. ,
DOI : 10.1182/blood-2012-05-402784
Targeted Deletion Reveals Essential and Overlapping Functions of the miR-17???92 Family of miRNA Clusters, Cell, vol.132, issue.5, pp.875-886, 2008. ,
DOI : 10.1016/j.cell.2008.02.019
miRiad Roles for the miR-17-92 Cluster in Development and Disease, Cell, vol.133, issue.2, pp.217-222, 2008. ,
DOI : 10.1016/j.cell.2008.04.001
A Polycistronic MicroRNA Cluster, miR-17-92, Is Overexpressed in Human Lung Cancers and Enhances Cell Proliferation, Cancer Research, vol.65, issue.21, pp.9628-9632, 2005. ,
DOI : 10.1158/0008-5472.CAN-05-2352
The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease, Cell Death and Differentiation, vol.48, issue.12, pp.1603-1614, 2013. ,
DOI : 10.1038/cdd.2013.125
Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes, Nature Immunology, vol.24, issue.4, pp.405-414, 2008. ,
DOI : 10.1038/ni1575
Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis, Blood, vol.119, issue.21, pp.4939-4948, 2012. ,
DOI : 10.1182/blood-2011-07-370122
MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes, Blood, vol.113, issue.2, pp.396-402, 2009. ,
DOI : 10.1182/blood-2008-07-163907
Overexpression of MicroRNAs from the miR-17-92 Paralog Clusters in AIDS-Related Non-Hodgkin's Lymphomas, PLoS ONE, vol.339, issue.6, p.20781, 2011. ,
DOI : 10.1371/journal.pone.0020781.s002
The miRNA-17???92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation, Leukemia, vol.3, issue.5, pp.1064-1072, 2012. ,
DOI : 10.1038/leu.2011.305
MicroRNA 17???92 expressed by a transposone-based vector changes expression level of cell-cycle-related genes, Cell Biology International, vol.8, issue.11, pp.1005-1012, 2012. ,
DOI : 10.1042/CBI20100515
A microRNA polycistron as a potential human oncogene, Nature, vol.1, issue.7043, pp.828-833, 2005. ,
DOI : 10.1093/BIOINFORMATICS/16.11.1046
Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancer, Oncogene, vol.107, issue.8, pp.1034-1044, 2012. ,
DOI : 10.1038/onc.2011.296
mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer, Molecular Cancer, vol.6, issue.1, p.54, 2007. ,
DOI : 10.1186/1476-4598-6-54
The miR-17-92 MicroRNA Cluster Regulates Multiple Components of the TGF-?? Pathway in Neuroblastoma, Molecular Cell, vol.40, issue.5, pp.762-773, 2010. ,
DOI : 10.1016/j.molcel.2010.11.038
The High Expression of the microRNA 17-92 Cluster and its Paralogs, and the Downregulation of the Target Gene PTEN, Is Associated with Primary Cutaneous B-Cell Lymphoma Progression. The Journal of investigative dermatology, pp.1659-1667, 2015. ,
BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas, The Journal of Pathology, vol.159, issue.2, pp.243-249, 2005. ,
DOI : 10.1002/path.1825
Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma, Blood, vol.125, issue.7, pp.1137-1145, 2015. ,
DOI : 10.1182/blood-2014-04-566778
A component of the mir-17- 92 polycistronic oncomir promotes oncogene-dependent apoptosis, eLife, vol.2, p.822, 2013. ,
Primary Mediastinal Large B-cell Lymphoma, Current Hematologic Malignancy Reports, vol.54, issue.8, pp.273-283, 2014. ,
DOI : 10.1007/s11899-014-0219-0
A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma, Proceedings of the National Academy of Sciences, vol.100, issue.17, pp.9991-9996, 2003. ,
DOI : 10.1073/pnas.1732008100
The FOXP1 Transcription Factor is Expressed in the Majority of Follicular Lymphomas but is Rarely Expressed in Classical and Lymphocyte Predominant Hodgkin???s Lymphoma, Journal of Molecular Histology, vol.17, issue.Suppl 1, pp.249-256, 2005. ,
DOI : 10.1007/s10735-005-6521-3
CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study, Blood, vol.121, issue.14, pp.2715-2724, 2013. ,
DOI : 10.1182/blood-2012-10-461848
Different biological risk factors in young poor-prognosis and elderly patients with diffuse large B-cell lymphoma, Leukemia, vol.6, issue.7, 2015. ,
DOI : 10.1182/blood-2013-11-536433
Immunohistochemical Methods for Predicting Cell of Origin and Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab, Journal of Clinical Oncology, vol.29, issue.2, pp.200-207, 2011. ,
DOI : 10.1200/JCO.2010.30.0368
A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy. Clinical cancer research : an official journal of the American www.impactjournals.com/oncotarget Association for Cancer Research, pp.5494-5502, 2009. ,
Immuno???Fluorescence In Situ Hybridization Index Predicts Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP: A GELA Study, Journal of Clinical Oncology, vol.27, issue.33, pp.5573-5579, 2009. ,
DOI : 10.1200/JCO.2009.22.7058
URL : https://hal.archives-ouvertes.fr/inserm-00424929
The Germinal Center/Activated B-Cell Subclassification Has a Prognostic Impact for Response to Salvage Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Bio-CORAL Study, Journal of Clinical Oncology, vol.29, issue.31, pp.4079-4087, 2011. ,
DOI : 10.1200/JCO.2011.35.4423
Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients, Leukemia, vol.118, issue.2, pp.362-372, 2014. ,
DOI : 10.1038/leu.2013.224
Subtype-specific addiction of the activated B-cell subset of diffuse large B-cell lymphoma to FOXP1, Proceedings of the National Academy of Sciences, vol.113, issue.5, pp.577-586, 2016. ,
DOI : 10.1073/pnas.1524677113
Expression of p21 Protein Predicts Clinical Outcome in DLBCL Patients Older than 60 Years Treated with R-CHOP but not CHOP: A Prospective ECOG and Southwest Oncology Group Correlative Study on E4494, Clinical Cancer Research, vol.16, issue.8, pp.2435-2442, 2010. ,
DOI : 10.1158/1078-0432.CCR-09-1219
FOXP1 directly represses transcription of proapoptotic genes and cooperates with NF-??B to promote survival of human B cells, Blood, vol.124, issue.23, pp.3431-3440, 2014. ,
DOI : 10.1182/blood-2014-01-553412
Gains ofREL in primary mediastinal B-cell lymphoma coincide with nuclear accumulation of REL protein, Genes, Chromosomes and Cancer, vol.82, issue.4, pp.406-415, 2007. ,
DOI : 10.1002/gcc.20420